IverMed™ – Right2Try

Description

lverMed™ is a registered trademark of Right2Try Inc™ and defined as lvermectin and its investigations into repurposed usage as a chemical compound that:

• Has antitumorigenic eﬀects by inhibiting the proliferation, metastasis and angiogenic activity of malignant cells.
• Regulates multiple signaling pathways through PAK1 kinase.
• Reverses multi-drug resistance.
• inhibits tumor stem cells.
• Possess anti-inﬂammation and anti-virus, properties.

1) https://www.ncbi.nlm.nih.gov/pmc/articles/P MC7S05114/
2) https://www.frontiersin.org/articles/10.3389/fphar.2021.717529/full
3) https://www.nature.com/articles/s41523-021-00229-5

Right2Try Inc.™ is a company that upholds the rights of patients with terminal diagnoses to choose alternative treatment options under the Right to Try Act of 2017.

1 Tablet = 12mg Ivermectin Excipients: dextrin, magnesium stearate, maize starch.

DISCLAIMER

Right2Try Inc. products are provided solely for laboratory research purposes. Only professionals who are qualified and licensed should handle this product. All information on this website is available for educational purposes only.

*Research chemicals are chemical substances used by scientists for medical and scientific research purposes. One characteristic of a research chemical is that it is for laboratory research use only; a research chemical is not intended for human or veterinary use. This distinction is required on the labels of research chemicals and is what exempts them from regulation under parts 100–740 in Title 21 of the Code of Federal Regulations (21CFR).